Search Results

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor Biology the highly-valued Odysseus Program Type I Program Grant to work as both the Adjunct Director of the VIB Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Joseph Kim exploring GPCR structural biology, cryo-electron microscopy, opioid receptor pharmacology, Joseph Kim: Structural Biology and Drug Discovery at GPCRs Scientific Abstract G protein-coupled receptors Joseph Kim discusses the intersection of structural biology, membrane protein biochemistry, and drug The discussion explores how structural biology technologies—particularly cryo-EM—have transformed the His work combines structural biology, membrane protein biochemistry, and pharmacological insights to

Moro, that he truly saw how molecules could go beyond the bench and interact with biology in powerful The Moment Chemistry Met Biology Nicoli’s turning point came when he realized that molecules weren’t biology. Modeling the Invisible: Olfactory Receptors Nicoli’s work centers on predicting ligand binding and receptor Alessandro Nicoli on the web Leibniz Institute for Food Systems Biology at the Technical University of

Demet Araç "Demet was an undergraduate at Bilkent University in Turkey, where she majored in Molecular Biology independent research career at the University of Chicago within the Department of Biochemistry and Molecular Biology Demet, who had studied various subjects including chemistry, physics, biology, and math, shared his interest Demet shared that his interest in science led him to study biology, genetics, and molecular biophysics biology and signaling assays.

, structural biologists, and drug-discovery veterans — drew on their combined experience to separate Yaroslav Nikolaev is a scientist at InterAx Biotech with a dual background in biology and computation His research combines biomolecular NMR, structural biology, and machine learning to study how GPCRs function University of New Mexico and coordinator of the Illuminating the Druggable Genome Knowledge Management Center The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide

systems Interrogating Incretin Receptor Biology Across Biological Complexity GLP-1 and GIP receptors chemical tools — including fluorescent ligands and photopharmacological compounds — to investigate GPCR biology selective fluorescent ligands for GPCRs, supporting researchers working at the interface of chemical biology It provides curated industry intelligence, expert-led masterclasses, and structured engagement opportunities drug discovery trends and developments Expert-led webinars and masterclasses with leading researchers Structured

. < Back The Spatiotemporal Revolution in GPCR Biology May 21, 2026 10:00 AM - 11:30 AM EST 🔒 Watch Designed for structural pharmacologists, cell biologists, and drug discovery scientists working on GPCR Cardiology at Duke University School of Medicine and Co-Director of the Duke Pulmonary Vascular Disease Center

Lukas Grätz "After a BSc in biology and a MSc in bioinformatics, I have been working in David Gloriam's branched out to multiple areas of GPCR research such as sequence alignments, generic numbering systems, structure As a developer, and more recently the lead developer of GPCRdb my day-to-day work centers around the Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

podcast list Strategic Partner(s) Gáspár Pándy-Szekeres About Gáspár Pándy-Szekeres " After a BSc in biology branched out to multiple areas of GPCR research such as sequence alignments, generic numbering systems, structure As a developer, and more recently the lead developer of GPCRdb my day-to-day work centers around the Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Her work spans GPCR structural biology, membrane protein stabilization, allosteric modulation, and the Years of assumed peptide biology dissolved into a simpler truth hidden in the solvent. microenvironment — immune cells, chemokine receptors, adenosine signaling — where GPCRs now sit at the center An expert in GPCR biology, Fiona published the first description of the cloning and structural requirements Richard Henderson at the Laboratory of Molecular Biology in Cambridge, UK.

uveal melanoma, GαS mutations across pancreatic, colon, and appendix cancers, and chemokine receptor biology biology, machine learning, and team science in GPCR pharmacology Key Insights from the Conversation Team science is structural, not decorative. hallway conversation, combining bioinformatics from Europe, high-throughput screens from Japan, and biology biology, machine learning, and the coupling problem 45:31 Two "what the heck" moments that became Nature

He walks through the structure his team built: staggered schedules at 10–15% occupancy, written contracts His research spans GPCR signaling in cancer biology, head and neck squamous cell carcinoma, and the molecular A small language correction with structural weight. Dr. J Silvio Gutkind on LinkedIn Gutkind Lab on Twitter UCSD Moores Cancer Center Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

biology—and where it still falls short Advice for junior scientists: what really matters when building biologists Early-career researchers exploring drug discovery Biotech leaders and R&D strategists Anyone interested in predictive modeling, AI in biology, or structure-function relationships About Jens Carlsson for collaborative science, Jens is a strong advocate for bringing together chemists, modelers, and biologists Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

currently a postdoc as a member of the personalized medicine cluster in Copenhagen and at the Institute of Biological Alexander has a big interest in the integration of large biomedical data in genomics, structural biology and pharmacoepidemiology with innovative computational methods to gain novel insights into receptor biology Alexander had a research sabbatical with Madan Babu at the MRC Laboratory of Molecular Biology in Cambridge Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Keith Moffat, he studied the structural mechanisms of bacterial photoreceptors using time-resolved Laue He then joined the Internal Medicine Residency training program at Duke University Medical Center. that causes right heart failure, and he serves as co-director of the Duke Pulmonary Vascular Disease Center Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

a Ph.D. degree in 2003 with a particular interest in the cardiovascular system by investigating the structure of the Angiotensin and Urotensin receptors through various biochemical approaches centered in the elucidation Boucard pursued postdoctoral training at the University of Texas Southwestern Medical Center in Dallas Mexico City to establish himself as an independent investigator integrating the department of Cell Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Teams expanding into antibody or biologic modalities for challenging GPCR targets. Pharmacology group in the Diabetes, Obesity and Complications Therapeutic Area at Lilly's Seaport Innovation Center His scientific training included a PhD at the International Center for Genetic Engineering and Biotechnology Awarded patents and a proven record in both target and pathway identification, his drive centers on integrating Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

His main research group centers on the function, structure, and regulation of G protein-coupled receptors Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through Turner Professor of Diabetic Medicine at the University of Oxford and a leading expert in metabolic GPCR biology By integrating advanced tools and translational biology, his work directly informs therapeutic strategies Institute for Molecular Pharmacology (FMP) Profile David Hodson Radcliffe Department of Medicine Islet Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

She has expertise in cell biology, pharmacology, translational medicine, oncology, immuno-oncology, immunology Previously, she held the position of Vice President of Cell Biology & Pharmacology, at Bristol-Myers She has extensive experience working with Biologics, and Antibody Drug Conjugates as well as experience issued U.S. patents including anti-PD-1 patents, 22 EP patents, and greater than 100 global patents centered Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

<< Back to podcast list Strategic Partner(s) Translating computational approaches to GPCR biologists He earned his PhD in Physics at the same university, focusing on in silico structural vaccinology and Scholar ResearchGate Bysky App : @ riccardocapelli.bsky.social Twitter X : @ ric_capelli Computational Structural Biology Upcoming Live Expert Sessions ➚ 🔒Explore the Full Masterclass ➚ Unlock the Full Dr. Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

non-psychedelic psychedelic for depression — and why the real bottleneck in GPCR drug discovery is the biology Louis University and trained in pharmacology at NIH and in molecular biology and psychiatry at Stanford It reframes the field's task from finding good targets to understanding the biology well enough to connect Louis University in 1983, he subsequently trained in pharmacology (NIH), molecular biology, and psychiatry Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

regulate over 800 receptors, why "non-canonical" GPCRs are nature's own biased receptors, and building a structural How two structurally similar proteins orchestrate such functional diversity across an entire receptor Arun Shukla leads a structural pharmacology lab in the Department of Biological Sciences and Bioengineering Episode Timeline 00:00 Introduction 02:15 From DNA quadruplexes to GPCR structural biology 06:32 The Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Subsequent work has focused on understanding the molecular basis of GPCR pharmacology through structure In 2016 mini-G proteins were developed as a tool for the structure determination of GPCRs in the fully to arrestin and also the first structure of a Class D receptor. web LinkedIn ResearchGate Pubmed Google Scholar Sosei Heptares Wikipedia MRC Laboratory of Molecular Biology Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Joseph Kim’s curiosity for science led him into GPCR research, drug discovery, and membrane protein biology—plus observed signaling outcomes, providing a bridge between structural biology and pharmacology. Nivedha reflects on how her career in GPCR biology began unexpectedly during her postdoctoral work. I was always interested in biology, especially studying anatomy. At the time, I didn’t realize the full scope of GPCR biology.

Membrane Proteins and Receptors (COMPARE), University of Nottingham, where he provides leadership in structural He joined the MRC Centre for Protein Engineering and later at the MRC Laboratory of Molecular Biology group leader at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural In 2017 Dmitry became a full professor at the Centre of Membrane Proteins and Receptors, COMPARE, a joined Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology

Di Pizio — who leads the computational pharmacology group at the Leibniz Institute for Food Systems Biology biology lab in Marburg. Antonella Di Pizio, an independent research group leader at the Leibniz Institute for Food Systems Biology biology. Antonella Di Pizio on the web Leibniz-Institute for Food Systems Biology at the Technical University

Communications, which she joined in April 2020, following three years on the editorial teams of Nature Structural and Molecular Biology and Nature Biotechnology. Katarzyna handles submissions in structural biology, biophysics and biochemistry, with a particular focus Advancing GPCR Imaging in Native Tissue How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology